Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 337 followers
Latest posts
Last updated 13 minutes ago
Argenx acquires Forte for $2.2B to get hands on phase 2-stage vitiligo drug
13 minutes ago
Argenx is spending $2.2 billion to absorb Forte Biosciences for its phase...
AstraZeneca execs ‘very confident’ in homegrown ADC pipeline despite scrapping 2 candidates
30 minutes ago
AstraZeneca executives told Fierce they are “very confident” in the pharma’s in-house...
Amgen sheds around 40 staffers amid continuing struggles
3 days ago
Amgen has laid off around 40 employees as part of “organizational changes”...
Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
3 days ago
A new analysis of patients who took part in clinical trials for...
Merck stages expanded access to monthly HIV PrEP pill ahead of approval
3 days ago
Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements...
Chutes & Ladders—Biogen R&D vet gets in Formation
3 days ago
AI-focused Formation Bio has found a new chief scientist with extensive experience...
Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout
3 days ago
Sanofi has abandoned plans to seek approval for amlitelimab in atopic dermatitis...
Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds
3 days ago
In vivo gene editing outfit Scribe Therapeutics has priced its IPO at...
Scancell to go public after winning reverse merger bid for troubled Neuphoria
4 days ago
Scancell and Neuphoria have made their union official via a reverse merger...
Roche Diagnostics growth remains muted amid China headwinds
4 days ago
Roche’s Diagnostics division continues to battle growth headwinds, notching a 3% increase...
Lilly’s triple-G drug hits 22.6% weight loss, but impact on reducing cardio risk is less clear
4 days ago
Eli Lilly’s triple-G drug retatrutide has hit the primary endpoints of a...
FDA clears Johnson & Johnson’s surgical robot for ‘the next era in surgery’
4 days ago
The FDA has authorized Johnson & Johnson’s Ottava Robotic Surgical System as...